Genprex

Recent Finacing

Equity

Recent Raise

Undisclosed

Genprex is an Austin-based biopharmaceutical company developing immunogene therapies, advancing lead product Oncoprex in a Phase II trial for stage IV non-small cell lung cancer combined with erlotinib.